Tums Naturals offer an antacid that is free of artificial flavors and dyes while offering multi-symptom relief of acid indigestion, sour stomach and burning in the chest.
Based on estimates, generic competition in the United States for seven complex products in AAM's analysis would yield annual savings between $600 million and $1.7 billion, with a median savings estimate of $1.3 billion.
In 2020, the FDA approved or tentatively approved 948 generic drug applications, including 72 first generics. The FDA also approved 30 generics under the Competitive Generic Therapy.
Drug Store News spoke with Kadenwood’s CEO and co-founder, Erick Dickens, to discuss what sets the company apart and the continued growth of CBD at mass.